THERAPEUTIC PHARMACEUTICAL PREPARATIONS MODULATING

Brand Owner (click to sort) Address Description
CARDIOMYOLEX LXR BIOTECHNOLOGY INC. 1401 Marina Way South Richmond CA 94804 therapeutic pharmaceutical preparations for modulating apoptosis related disorders;
ELIREX LXR BIOTECHNOLOGY INC. 1401 Marina Way South Richmond CA 94804 therapeutic pharmaceutical preparations for modulating apoptosis related disorders;
ELIREX LXR BIOTECHNOLOGY INC. 1401 Marina Way South Richmond CA 94804 THERAPEUTIC PHARMACEUTICAL PREPARATIONS FOR MODULATING APOPTOSIS RELATED DISORDERS;
LEXIRIN LXR BIOTECHNOLOGY INC. 1401 Marina Way South Richmond CA 94804 therapeutic pharmaceutical preparations for modulating apoptosis related disorders;
LEXIRIN Kenrico Ltd. 1738-2 Kikugawa Shimada 428-0037 Japan Therapeutic pharmaceutical preparations for modulating apoptosis related disorders;
LXR LXR BIOTECHNOLOGY INC. 1401 Marina Way South Richmond CA 94804 therapeutic pharmaceutical preparations for modulating apoptosis related disorders;
LXR LXR BIOTECHNOLOGY INC. 1401 Marina Way South Richmond CA 94804 therapeutic pharmaceutical preparations for modulating apoptosis related disorders; organ preservation solutions for the preservation of live tissue for medical use;organ preservation solutions for scientific or laboratory use;
LXR BIOTECHNOLOGY LXR BIOTECHNOLOGY INC. 1401 Marina Way South Richmond CA 94804 therapeutic pharmaceutical preparations for modulating apoptosis related disorders;BIOTECHNOLOGY;
LXR015 LXR BIOTECHNOLOGY INC. 1401 Marina Way South Richmond CA 94804 THERAPEUTIC PHARMACEUTICAL PREPARATIONS FOR MODULATING APOPTOSIS RELATED DISORDERS;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. The present invention provides pharmaceutical preparations and the uses thereof for preventing and/or treating seizures and other electroconvulsive disorders by administering a pharmaceutically effective amount of a therapeutic compound having the following formula (I):